Fra­zier backs MavuPhar­ma’s $20M round, brings in heavy­weight ex­ecs to lead

Ven­ture part­ners at Fra­zier have put to­geth­er a dream team from their ex­ec­u­tive rolodex to a lead a new start­up called MavuPhar­ma. The new ven­ture …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.